Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
University of Washington · Institute for Health Metrics and Evaluation · +1557 more institutions
Abstract
Timely and comprehensive analyses of causes of death stratified by age, sex, and location are essential for shaping effective health policies aimed at reducing global mortality. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 provides cause-specific mortality estimates measured in counts, rates, and years of life lost (YLLs). GBD 2023 aimed to enhance our understanding of the relationship between age and cause of death by quantifying the probability of dying before age 70 years (70q0) and the mean age at death by cause and sex. This study enables comparisons of the impact of causes of death over time, offering a deeper understanding of how these causes affect global populations.
GBD 2023 produced estimates for 292 causes of death disaggregated by age-sex-location-year in 204 countries and territories and 660 subnational locations for each year from 1990 until 2023. We used a modelling tool developed for GBD, the Cause of Death Ensemble model (CODEm), to estimate cause-specific death rates for most causes. We computed YLLs as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. Probability of death was calculated as the chance of dying from a given cause in a specific age period, for a specific population. Mean age at death was calculated by first assigning the midpoint age of each age group for every death, followed by computing the mean of all midpoint ages across all deaths attributed to a given cause. We used GBD death estimates to calculate the observed mean age at death and to model the expected mean age across causes, sexes, years, and locations. The expected mean age reflects the expected mean age at death for individuals within a population, based on global mortality rates and the population's age structure. Comparatively, the observed mean age represents the actual mean age at death, influenced by all factors unique to a location-specific population, including its age structure. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 250-draw distribution for each metric. Findings are reported as counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2023 include a correction for the misclassification of deaths due to COVID-19, updates to the method used to estimate COVID-19, and updates to the CODEm modelling framework. This analysis used 55 761 data sources, including vital registration and verbal autopsy data as well as data from surveys, censuses, surveillance systems, and cancer registries, among others. For GBD 2023, there were 312 new country-years of vital registration cause-of-death data, 3 country-years of surveillance data, 51 country-years of verbal autopsy data, and 144 country-years of other data types that were added to those used in previous GBD rounds.
Citation impact
- FWCI
- 904.86
- Percentile
- 100%
- References
- 42
Authors
2463- MNMohsen NaghaviCorresponding
University of Washington, Institute for Health Metrics and Evaluation
- HHHmwe Hmwe Kyu
University of Washington, Institute for Health Metrics and Evaluation
- ABA Bhoomadevi
Amity University
- MAMohammad Amin Aalipour
Shahid Beheshti University of Medical Sciences
- HAHasan Aalruz
Al-Zaytoonah University of Jordan
Topics & keywords
- Burden of disease
- Disease burden
- Disease
- Global health
- Double burden
- Cause of death
Funding
- NHNepal Health Research Council, Government of Nepal
- DADavid and Lucile Packard Foundation
- USUnited States Agency for International DevelopmentAward: GPO-A-00\u201308\u2013000_D3\u201300
- BABill and Melinda Gates FoundationAward: OPP1152504
- GAGAVI AllianceAward: OPP1152504
- PHPublic Health Institute
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- BBayer
- SSanofiAward: 2010-2011
- WHWorld Health Organization
- YUYale University
- GSGilead Sciences
- BBiogen
- TPTeva Pharmaceutical Industries
- UOUniversity of California Berkeley
- UOUniversity of Michigan
- SJSt. Jude Children's Research Hospital
- TUTufts University
- IPInternational Parkinson and Movement Disorder Society
- QHQueensland Health
- WTWellcome TrustAwards: 2023-24, 300957, R01AG031716, 072406
- IAInternational Association for Suicide Prevention
- IFInstitute for Health Metrics and EvaluationAward: SLN2019\u20138-64
- EFEuropean Food Safety Authority
- FMFresenius Medical Care North America
- MOMinistry of Health and Population
- GRGilead Research Scholars
- SMSociedad Madrileña de Nefrología
- MCMinisterul Cercetării, Inovării şi DigitalizăriiAwards: 7N/2023, PNRR-C9-I8-CF 267
- NINational Institute of Mental Health and Neurosciences
- U'Universitatea 'Dunărea de Jos' Galați
- NINational Institute for Health and Care ResearchAward: 300957
- DODepartment of Health and Social Care
- ECEuropean CommissionAwards: PNRR/2022/C9/MCID/I8, 300957, 2020-2023, 2023-24, 2011-2013, 2022-2027
- UOUniversity of Tasmania
- HPHealth Protection Agency
- DODepartment of Biotechnology, Ministry of Science and Technology, India
- DODepartment of Science and Technology, Ministry of Science and Technology, IndiaAward: 2020-2023
- ICIndian Council of Medical ResearchAward: 2023-24
- MOMinistry of Health, New Zealand
- MOMinistry of Education, Culture, Sports, Science and TechnologyAwards: 24H00663, 2020-2023, 2005-2006
- UOUniversity of Sydney
- MUMonash University
- BFBundesministerium für Bildung und Forschung
- MDMinistero della SaluteAward: 34/2017
- MMax-Planck-Gesellschaft
- NNNovo Nordisk
- MOMinistry of Public Health
- APAstellas Pharma
- UDUniversidad de Costa Rica
- SSocialdepartementet
- UOUniversity of Ghana
- UDUniversité de Lausanne
- MOMinistry of Health, State of Israel
- NRNational Research University Higher School of Economics
- MOMinistry of Health and Family Welfare
- UVUniversiteit van Tilburg
- PUPeking UniversityAward: 2021-5
- AAAddis Ababa University
- TWThe Wellcome Trust DBT India Alliance
- SOSwedish Orphan Biovitrum
- HLH. Lundbeck A/S
- NINational Institute for Medical Research
- SPSuicide Prevention Australia
- NSNational Science and Technology Council
- TDTasmanian Department of Health
- NINational Institutes of HealthAwards: 2R01AG057531, NIH R01AG018016, 2R01AG057531-02A1, 2010-2011, R21AG032572, 2020-2023, R01AG018016, R03AG043052, R01 AG030153
- CFCenters for Disease Control and Prevention
- RSRollins School of Public Health
- SFSeventh Framework ProgrammeAwards: N 227822, N 261982, N 211909
- FFFifth Framework ProgrammeAward: QLK6-CT-2001-00360
- EGEconomic Growth Center, Yale University
- MRMedical Research Council
- EEurostat
- NHNational Health and Medical Research CouncilAwards: APP2009306, 2023-2025, APP1169489
- SAScience and Engineering Research Board
- JSJapan Science and Technology AgencyAward: JPMJPR22R8
- SFSixth Framework ProgrammeAwards: RII-CT-2006-062193, CIT4-CT-2006-028812, CIT5-CT-2005-028857
- FOFaculty of Science, Agriculture and Engineering, Newcastle University
- BIBiotechnology Industry Research Assistance Council
- NINorwegian Institute of Public Health
- NINational Institute on AgingAwards: HHSN271201300071C, R01-AG034479, U01_AG09740-13S2, OGHA 04034785, P30_AG12815, P01_AG005842, R21_AG025169, R21-AG034263, OGHA_04-064, IAG_BSR06-11, P01_AG08291, Y1-AG-4553-01, U01AG009740, YA1323\u201308-CN-0020, Y1-AG-1005\u20130
- NINational Institute of Mental Health
- NCNational Center for Health Statistics
- EKEunice Kennedy Shriver National Institute of Child Health and Human Development
- PRPrecursory Research for Embryonic Science and TechnologyAward: JPMJPR22R8
- ICInstitut canadien d'information sur la santé